评估炎症性肠道疾病中的炎症性蛋白质因素,使用多变量门德尔随机化
Qiang Su1, Yun Lu1,2, Song He3
1First Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
Scientific reports
|January 3, 2025
概括
门德尔的随机化确定了与炎症性肠病 (IBD) 相关的关键炎症蛋白质,包括性结肠炎 (UC) 和克罗恩氏病.
科学领域:
- 遗传学和分子生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎 (UC) 和克罗恩病 (CD),显著影响患者的生活质量,并导致残疾.
- 驱动IBD病原体的精确基础生物机制仍然不完全理解.
- 确定与IBD相关的特定分子因素对于推进早期诊断和治疗策略至关重要.
研究的目的:
- 使用门德尔随机化 (MR) 分析来识别特定的炎症性细胞因子和与UC和CD遗传相关的蛋白质.
- 探索炎症蛋白和IBD亚型之间的共享遗传结构.
- 为IBD查,预防和治疗提供潜在生物标志物的见解.
主要方法:
- 利用全基因组关联研究 (GWAS) 关于欧洲队列 (n=14,824) 炎症性细胞因子水平的数据.
- 使用逆变量加权 (IVW),MR-Egger和加权中位数方法进行了门德尔随机化 (MR) 分析,并使用了UC和CD的总结级GWAS数据.
- 进行了灵敏度分析 (Cochran's Q,MR-Egger拦截,MR-PRESSO,留出一个),施泰格和反向MR测试,多变量MR (MVMR),LDSC和同位分析.
主要成果:
- 确定了特定的炎症蛋白和IBD亚型之间的显著遗传关联.FDR后纠正.
- CXCL5和CXCL9与UC显著相关;CXCL5和IL-18R1与CD显著相关.
- 局部化分析揭示了炎症蛋白 (CXCL5与UC,CXCL9与CD) 和IBD之间的共同遗传变异,表明了共同的遗传决定因素.
结论:
- 这项研究提供了强有力的证据,证明了几种炎症蛋白因子与UC和CD之间的遗传关联.
- 这些发现突出了CXCL5,CXCL9和IL-18R1等特定蛋白质作为IBD病原体的潜在贡献者.
- 鉴定的遗传联系为IBD的生物机制提供了新的见解,并为未来的治疗干预提供了潜在的目标.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
01:29Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135